Induction of the upstream regulatory region of human papillomavirus type 31 by dexamethasone is differentiation dependent

Journal of Virology

Volumn 77, Issue 20, 2003, Pages 10975-10983

  Bromberg White, Jennifer L ^a,b   Sen, Ellora ^a   Alam, Samina ^a   Bodily, Jason M ^a   Meyers, Craig ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

ARTICLE; GENE STRUCTURE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 31; LIFE CYCLE; PRIORITY JOURNAL; REGULATORY MECHANISM; REPRESSOR GENE; TISSUE DIFFERENTIATION; UPSTREAM REGULATORY REGION; WART VIRUS;

CELL DIFFERENTIATION; CELLS, CULTURED; DEXAMETHASONE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; PAPILLOMAVIRIDAE; REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 0141566322     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.20.10975-10983.2003     Document Type: Article

References (50)

1. Ai, W., J. Marahari, and A. Roman. 2000. Yin Yang 1 negatively regulates the differentiation-specific E1 promoter of human papillomavirus type 6. J. Virol. 74:5198-5205.
2. Ai, W., E. Toussaint, and A. Roman. 1999. CCAAT displacement protein binds to and negatively regulates human papillomavirus type 6 E6, E7, and E1 promoters. J. Virol. 73:4220-4229.
3. Antinore, M. J., M. J. Birrer, D. Patel, L. Nader, and D. J. McCance. 1996. The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors. EMBO J. 15:1950-1960.
4. Apt, D., R. Watts, G. Suske, and H. Bernard. 1996. High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology 224:281-291.
5. Aumais, J. P., H. S. Lee, C. DeGannes, J. Horsford, and J. H. White. 1996. Function of directly repeated half-sites as response elements for steroid hormone receptors. J. Biol. Chem. 271:12568-12577.
6. Becker, P. B., B. Gloss, W. Schmid, U. Strahle, and G. Schutz. 1986. In vivo protein-DNA interactions in a glucocorticoid response element require the presence of the hormone. Nature 324:686-638.
7. Bedell, M., J. Hudson, T. Golub, M. Turyk, M. Hosken, G. Wilbanks, and L. Laimins. 1991. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J. Virol. 65:2254-2260.
8. Biola, A., P. Lefebvre, M. Perrin-Wolff, M. Sturm, J. Bertoglio, and M. Pallardy. 2001. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1. Mol. Endocrinol. 15:1062-1076.
9. Broker, T., and M. Botchan. 1986. Papillomaviruses: retrospectives and prospectives. Cancer Cells 4:17-36.
10. Bromberg-White, J. L., and C. Meyers. 2002. The upstream regulatory region of human papillomavirus type 31 is insensitive to glucocorticoid induction. J. Virol. 76:9702-9715.
11. Bruggemeier, U., M. Kalff, S. Franke, C. Scheidereit, and M. Beato. 1991. Ubiquitous transcription factor OTF-1 mediates induction of the MMTV promoter through synergistic interaction with hormone receptors. Cell 64:565-572.
12. Butz, K., and F. Hoppe-Seyler. 1993. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. J. Virol. 67:6476-6486.
13. 2u-globulin DNA. J. Biol. Chem. 266:22634-22644.
14. Chan, W., G. Klock, and H. Bernard. 1989. Progesterone and glucocorticoid response elements occur in the long control region of several human papillomaviruses involved in anogenital neoplasia. J. Virol. 63:3261-3269.
15. Eckert, R., J. Crish, and N. Robinson. 1997. The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol. Rev. 77:397-424.
16. Flores, E. R., and P. F. Lambert. 1997. Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J. Virol. 71:7167-7179.
17. Frattini, M. G., H. B. Lim, and L. A. Laimins. 1996. In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression. Proc. Natl. Acad. Sci. USA 93:3062-3067.
18. Garlatti, M., M. Daheshia, E. Slater, J. Bouguet, J. Hanoune, M. Beato, and R. Barouki. 1994. A functional glucocorticoid-responsive unit composed of two overlapping inactive receptor-binding sites: evidence for formation of a receptor tetramer. Mol. Cell. Biol. 14:8007-8017.
19. Gloss, B., H. U. Bernard, K. Seedorf, and G. Klock. 1987. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J. 6:3735-3743.
20. Grassmann, K., B. Rapp, H. Mascjek, K. Petry, and T. Ifner. 1996. Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J. Virol. 70:2339-2349.
21. Howley, P. 1996. Papillomavirinae: the viruses and their replication, p. 2045-2076. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
22. Hummel, M., J. B. Hudson, and L. A. Laimins. 1992. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J. Virol. 66:6070-6080.
23. Hummel, M., H. Lim, and L. Laimins. 1995. Human papillomavirus type 31b late gene expression is regulated through protein kinase C-mediated changes in RNA processing. J. Virol. 69:3381-3388.
24. Jeon, S., B. L. Allen-Hoffmann, and P. F. Lambert. 1995. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69:2989-2997.
25. Jonat, C., H. Rahmsdorf, K. Park, A. Cato, S. Gebel, H. Ponta, and P. Herrlich. 1990. Antitumor promotion and antiinflammation: down-modulation of AP1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189-1204.
26. Kyo, S., A. Tam, and L. A. Laimins. 1995. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors. Virology 211:184-197.
27. Lambert, P. F. 1991. Papillomavirus DNA replication. J. Virol. 65:3417-3420.
28. Li, Q., and O. Wrange. 1995. Accessibility of a glucocorticoid response element in a nucleosome depends on its rotational positioning. Mol. Cell. Biol. 15:4375-4384.
29. Li, S., S. Labrecque, M. C. Gauzzi, A. R. Cuddihy, A. H. Wong, S. Pellegrini, G. J. Matlashewski, and A. E. Koromilas. 1999. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α. Oncogene 18:5727-5737.
30. Medina-Martinez, O., N. Morales-Peza, M. Yaniv, A. Garcia-Carranca, and F. Thierry. 1996. A single element mediates glucocorticoid hormone response of HPV18 with no functional interactions with AP1 or hbrm. Virology 217:392-396.
31. Meyers, C. 1996. Organotypic (raft) epithelial tissue culture system for the differentiation-dependent replication of papillomavirus. Methods Cell Sci. 18:1-10.
32. Meyers, C., M. Frattini, J. Hudson, and L. Laimins. 1992. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257:971-973.
33. Meyers, C., T. Mayer, and M. Ozbun. 1997. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J. Virol. 71:7381-7386.
34. Mukhopadhyay, S. S., S. L. Wyszomierski, R. M. Gronostajski, and J. M. Rosen. 2001. Differential interactions of specific nuclear factor I isoforms with the glucocorticoid receptor and STAT5 in the cooperative regulation of WAP gene transcription. Mol. Cell. Biol. 21:6859-6869.
35. Ozbun, M., and C. Meyers. 1997. Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J. Virol. 71:5161-5172.
36. Ozbun, M., and C. Meyers. 1998. Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. J. Virol. 72:2715-2722.
37. Petz, L. N., A. M. Nardulli, J. Kim, K. B. Horwitz, L. P. Freedman, and D. J. Shapiro. 1997. DNA bending is induced by binding of the glucocorticoid receptor DNA binding domain and progesterone receptors to their response element. J. Steroid Biochem. Mol. Biol. 60:31-41.
38. Ruesch, M., F. Stubenrauch, and L. Laimins. 1998. Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10. J. Virol. 72:5016-5024.
39. Schule, R., P. Rangarajan, S. Kliewer, L. J. Ransone, J. Bolado, N. Yang, I. M. Verma, and R. M. Evans. 1990. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217-1226.
40. Sen, E., J. L. Bromberg-White, and C. Meyers. 2002. Genetic analysis of cis regulatory elements within the 5′ region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle. J. Virol. 76:4798-4809.
41. Stoler, M. H., S. M. Wolinsky, A. Whitbeck, T. R. Broker, and L. T. Chow. 1989. Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 172:331-340.
42. Strahle, U., G. Klock, and G. Schutz. 1987. A DNA sequence of 15 base pairs is sufficient to mediate both glucocorticoid and progesterone induction of gene expression. Proc. Natl. Acad. Sci. USA 84:7871-7875.
43. Takeda, T., H. Kurachi, T. Yamamoto, Y. Nishio, Y. Nakatsuji, K. Morishige, A. Miyake, and Y. Murata. 1998. Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid. J. Endocrinol. 159:323-330.
44. Truss, M., and M. Beato. 1993. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr. Rev. 14:459-479.
45. Ustav, M., and A. Stenlund. 1991. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J. 10:449-457.
46. Wyszomierski, S. L., and J. M. Rosen. 2001. Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPβ (CCAAT/enhancer-binding protein-β) on beta-casein gene transcription are mediated by the glucocorticoid receptor. Mol. Endocrinol. 15:228-240.
47. Yang-Yen, H. F., J. C. Chambard, Y. L. Sun, T. Smeal, T. J. Schmidt, J. Drouin, and M. Karin. 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-1215.
48. Zhao, W., L. T. Chow, and T. R. Broker. 1997. Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes. J. Virol. 71:8832-8840.
49. Zhu, Q., and J. P. Dudley. 2002. CDP binding to multiple sites in the mouse mammary tumor virus long terminal repeat suppresses basal and glucocorticoid-induced transcription. J. Virol. 76:2168-2179.
50. Zwerschke, W., S. Joswig, and P. Jansen-Durr. 1996. Identification of domains required for transcriptional activation and protein dimerization in the human papillomavirus type-16 E7 protein. Oncogene 12:213-220.